Impact of ATG use on the outcome of patients with hematological malignancies undergoing reduced-intensity conditioning for allogeneic hematopoietic cell transplantation

被引：0

作者：

Greinix, H. ^{[1
]}

Beohou, E. ^{[1
]}

van der Werf, S. ^{[2
]}

Niederwieser, D. ^{[3
]}

Blaise, D. ^{[4
]}

Dreger, P. ^{[5
]}

Arnold, R. ^{[6
]}

Meijer, E. ^{[7
]}

Sengeloev, H. ^{[8
]}

Cornelissen, J. ^{[9
]}

Hallek, M. ^{[10
]}

Socie, G. ^{[11
]}

Chevallier, P. ^{[12
]}

Ganser, A. ^{[13
]}

Milpied, N. ^{[14
]}

Maertens, J. ^{[15
]}

Petersen, E. ^{[16
]}

Afanasyev, B. ^{[17
]}

Ehninger, G. ^{[18
]}

Fegueux, N. ^{[19
]}

Jindra, P. ^{[20
]}

Kroeger, N. ^{[21
]}

Montoto, S. ^{[22
]}

Nagler, A. ^{[23
]}

Duarte, R. ^{[24
]}

机构：

[1] EBMT Paris Study Off CEREST TC, Paris, France

[2] EBMT Study Coordinat Off, Leiden, Netherlands

[3] Univ Hosp Leipzig, Leipzig, Germany

[4] Inst Paoli Calmettes, Marseille, France

[5] Heidelberg Univ, Heidelberg, Germany

[6] Charite Univ Med Berlin, Berlin, Germany

[7] VU Univ Med Ctr Amsterdam, Amsterdam, Netherlands

[8] Rigshosp Copenhagen, Copenhagen, Denmark

[9] Erasmus MC Canc Inst Rotterdam, Rotterdam, Netherlands

[10] Univ Cologne, Cologne, Germany

[11] Hop St Louis Paris, Paris, France

[12] CHU Nantes, Nantes, France

[13] Hannover Med Sch, Hannover, Germany

[14] CHU Bordeaux, Bordeaux, France

[15] Univ Hosp Gasthuisberg, Leuven, Belgium

[16] Univ Med Ctr Utrecht, Utrecht, Netherlands

[17] First State Pavlov Med Univ St Petersburg, St Petersburg, Russia

[18] Univ Klinikum Dresden, Dresden, Germany

[19] CHU Lapeyronie Montpellier, Montpellier, France

[20] Charles Univ Hosp Pilsen, Plzen, Czech Republic

[21] Univ Hosp Eppendorf, Hamburg, Germany

[22] St Bartholomews & Royal London NHS Trust, London, England

[23] Chaim Sheba Med Ctr, Tel Hashomer, Israel

[24] Hosp Univ Puerta de Hierro Madrid, Madrid, Spain

来源：

BONE MARROW TRANSPLANTATION | 2017年 / 52卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O084

引用

页码：S61 / S61

页数：1

共 50 条

[21] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
Nihtinen, A
Volin, L
Juvonen, E
Ruutu, T
BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
[22] Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases
U. Platzbecker
G. Ehninger
N. Schmitz
M. Bornhäuser
Annals of Hematology, 2003, 82 : 463 - 468
[23] A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis
Gupta, V.
Kroeger, N.
Aschan, J.
Xu, W.
Leber, B.
Dalley, C.
Sabloff, M.
Lipton, J. H.
Messner, H.
Brune, M.
BONE MARROW TRANSPLANTATION, 2009, 44 (05) : 317 - 320
[24] A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis
V Gupta
N Kröger
J Aschan
W Xu
B Leber
C Dalley
M Sabloff
J H Lipton
H Messner
M Brune
Bone Marrow Transplantation, 2009, 44 : 317 - 320
[25] Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias
Niederwieser, D
Gentilini, C
Hegenbart, U
Lange, T
Becker, C
Wang, SY
Bartsch, K
Pönisch, W
Raida, M
Al-Ali, H
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (02) : 275 - 281
[26] Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction
Zamora-Ortiz, Gabriela
Velazquez-Sanchez-de-Cima, Sara
Ponce-de-Leon, Sergio
Homero Gutierrez-Aguirre, Cesar
Jose Ruiz-Delgado, Guillermo
Gomez-Almaguer, David
Jose Ruiz-Argueelles, Guillermo
HEMATOLOGY, 2014, 19 (08) : 435 - 440
[27] Feasibility of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens for refractory myeloid malignancies.
Hamaki, T
Kami, M
Kim, SW
Yamamoto, R
Imataki, O
Suyama, H
Arima, F
Nakai, K
Saito, T
Kanda, Y
Makimoto, A
Tanosaki, R
Mineishi, S
Takaue, Y
BLOOD, 2002, 100 (11) : 851A - 851A
[28] Impact of age on outcome of reduced-intensity conditioning with fludarabine and busulfan for allogeneic haematopoietic cell transplantation
Schneidawind, D.
Federmann, B.
Helwig, A.
Vogel, W.
Faul, C.
Kanz, L.
Bethge, W. A.
BONE MARROW TRANSPLANTATION, 2013, 48 : S230 - S230
[29] Reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in 60 adult patients with hematological malignancies in single center experience
Gil, L
Kozlowska-Skrzypczak, M
Sawinski, K
Gozdzik, J
Czyz, A
Hansz, J
Komarnicki, M
BONE MARROW TRANSPLANTATION, 2003, 31 : S145 - S145
[30] Second Malignancies after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning: Is the Incidence Reduced?
Shimoni, Avichai
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1669 - 1670

← 1 2 3 4 5 →